Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

MEDU

Medgenics (MEDU)

Medgenics
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:MEDU
FechaHoraFuenteTítuloSímboloCompañía
15/04/201407:30UK RegulatoryMedgenics Inc $2.2 Million Grant AwardLSE:MEDUMedgenics
09/04/201407:30UK RegulatoryMedgenics Inc Results of 2014 Annual MeetingLSE:MEDUMedgenics
05/03/201407:30UK RegulatoryMedgenics Inc Presenting at ROTH Capital Growth ConferenceLSE:MEDUMedgenics
17/02/201402:00UK RegulatoryMedgenics Inc Directors DealingsLSE:MEDUMedgenics
13/01/201401:00UK RegulatoryMedgenics Inc Director's DealingLSE:MEDUMedgenics
07/01/201412:00UK RegulatoryMedgenics Inc Block Listing Interim ReviewLSE:MEDUMedgenics
24/12/201306:30UK RegulatoryMedgenics Inc Director enters into Stock Trading PlanLSE:MEDUMedgenics
18/12/201307:30UK RegulatoryMedgenics Inc Purchase of Common Stock by DirectorLSE:MEDUMedgenics
16/12/201308:00UK RegulatoryMedgenics Inc Purchase of Common Stock by ChairmanLSE:MEDUMedgenics
04/11/201308:00UK RegulatoryMedgenics Inc Medgenics to Host Business Update Conference CallLSE:MEDUMedgenics
28/10/201302:01UK RegulatoryMedgenics Inc Medgenics Reports Positive Data At ESGCT CongressLSE:MEDUMedgenics
17/10/201307:00UK RegulatoryMedgenics Inc Appoints Bill Gantz to its Board of DirectorsLSE:MEDUMedgenics
01/10/201302:30UK RegulatoryMedgenics Inc Appointment of Nominated Adviser and Joint BrokerLSE:MEDUMedgenics
09/07/201308:00UK RegulatoryMedgenics Inc $1.9 Million Grant Awarded from the Israeli OCSLSE:MEDUMedgenics
01/05/201308:15UK RegulatoryMedgenics Inc Results of 2013 Annual Meeting of StockholdersLSE:MEDUMedgenics
25/04/201308:15UK RegulatoryMedgenics Inc Positive Interim Data from Phase IIa EPODURE StudyLSE:MEDUMedgenics
22/04/201308:15UK RegulatoryMedgenics Inc Notice of Allowance for Claims that Expand IPLSE:MEDUMedgenics
20/06/201210:00UK RegulatoryReceives Orphan Drug Designation from FDALSE:MEDUMedgenics
19/06/201208:25UK RegulatoryMedgenics, Inc. Raises $9.5 millionLSE:MEDUMedgenics
07/06/201209:30UK RegulatoryMedgenics Initiates U.S. Biopump Processing SiteLSE:MEDUMedgenics
29/05/201201:02UK RegulatoryChange of NOMADLSE:MEDUMedgenics
17/05/201209:00UK RegulatoryFDA Clearance for Phase IIb Trial of EPODURELSE:MEDUMedgenics
14/05/201212:09UK Regulatory1st Quarter ResultsLSE:MEDUMedgenics
09/05/201209:00UK RegulatoryMedgenics Awarded $2.2 Million GrantLSE:MEDUMedgenics
27/04/201201:00UK RegulatoryMedgenics Comments on Market Trading ActivityLSE:MEDUMedgenics
23/04/201209:00UK RegulatoryMedgenics files for U.S. Orphan Drug DesignationLSE:MEDUMedgenics
17/04/201209:15UK RegulatoryIND Application for Phase IIb EPODURE Anemia StudyLSE:MEDUMedgenics
05/04/201210:15UK RegulatoryAGM StatementLSE:MEDUMedgenics
26/03/201209:00UK RegulatoryPositive meeting with NIH RACLSE:MEDUMedgenics
23/03/201209:00UK RegulatoryClearance to initiate Phase IIA Anemia StudyLSE:MEDUMedgenics
 Showing the most relevant articles for your search:LSE:MEDU